Simone Lorenzut
Overview
Explore the profile of Simone Lorenzut including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
219
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lorenzut S, Negro I, Pauletto G, Verriello L, Spadea L, Salati C, et al.
J Integr Neurosci
. 2025 Jan;
24(1):25081.
PMID: 39862004
The complicated neurological syndrome known as multiple sclerosis (MS) is typified by demyelination, inflammation, and neurodegeneration in the central nervous system (CNS). Managing this crippling illness requires an understanding of...
2.
Merlino G, Romoli M, Ornello R, Foschi M, Del Regno C, Toraldo F, et al.
Eur Stroke J
. 2024 Apr;
9(3):613-622.
PMID: 38624043
Introduction: Mechanical thrombectomy (MT) is the standard treatment for acute ischemic stroke (AIS) due to anterior large vessel occlusion (LVO). Despite successful recanalization, some patients remain disabled after 3 months....
3.
DAnna L, La Cava R, Khetarpal A, Karjikar A, Almohtadi A, Romoli M, et al.
Front Cardiovasc Med
. 2024 Mar;
11:1369914.
PMID: 38500754
Background: Covert atrial fibrillation (AF) is a predominant aetiology of embolic stroke of undetermined source (ESUS). Evidence suggested that AF is more frequently detected by implantable loop recorder (ILR) than...
4.
Kuris F, Tartaglia S, Sperotto R, Ceccarelli L, Bagatto D, Lorenzut S, et al.
Front Neurol
. 2024 Mar;
15:1332382.
PMID: 38487322
Background And Purpose: Isolated insular strokes (IIS) are a rare occurrence due to the frequent concomitant involvement of adjacent territories, supplied by the M2 segment of the middle cerebral artery...
5.
Dal Bello S, Lorenzut S, Saccomano E, Tereshko Y, Gigli G, Pucillo C, et al.
Pharmaceuticals (Basel)
. 2024 Feb;
17(2).
PMID: 38399365
Background: Recently, research on the pathogenesis of multiple sclerosis (MS) has focused on the role of B lymphocytes and the possibility of using specific drugs, such as Ocrelizumab and Rituximab,...
6.
Mare A, Lorenzut S, Janes F, Gentile C, Marinig R, Tereshko Y, et al.
Expert Opin Drug Metab Toxicol
. 2024 Jan;
20(1-2):25-36.
PMID: 38275111
Introduction: The drug most frequently used for thrombolysis in cases of acute ischemic stroke (AIS) is alteplase. However, there is moderate-to-high-quality evidence that tenecteplase has similar or higher efficacy and...
7.
Bax F, Pizzamiglio L, Lorenzut S, Merlino G, Ceccarelli L, Janes F, et al.
Acta Neurol Belg
. 2023 Dec;
124(2):503-511.
PMID: 38072895
Background: Rehabilitation is currently the best available treatment for post-stroke disability. There is, however, great variability in the proportion of patients accessing rehabilitation across high-income countries suggesting that factors not...
8.
Merlino G, Garbo R, Dal Bello S, Negro I, Lamon E, Filippi F, et al.
Sleep Med
. 2023 Oct;
112:181-187.
PMID: 37879260
Objective/background: Patients with multiple sclerosis (MS) frequently report sleep complaints. The ketogenic diet (KD) is safe and tolerable in MS patients. Our aim was: 1) to investigate the effects of...
9.
Merlino G, Nesi L, Vergobbi P, Scanni M, Pez S, Marziali A, et al.
Front Neurol
. 2023 Aug;
14:1212712.
PMID: 37528859
Introduction: It is unknown whether alteplase is effective and safe in patients with mild acute ischemic stroke (AIS). Determining whether symptoms are "disabling" or not is a crucial factor in...
10.
Merlino G, Pez S, Sartor R, Kuris F, Tereshko Y, Nesi L, et al.
Front Neurol
. 2023 Jun;
14:1170215.
PMID: 37273693
Introduction: Mechanical thrombectomy (MT) is the first line treatment in acute ischemic stroke (AIS) due to large vessel occlusion (LVO). Approximately half of patients treated with MT does not have...